Drug Shortage Report for SANDOZ RIVASTIGMINE PATCH 10

Last updated on 2024-04-03 History
Report ID 224174
Drug Identification Number 02426307
Brand name SANDOZ RIVASTIGMINE PATCH 10
Common or Proper name RIVASTIGMINE PATCH 10
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RIVASTIGMINE
Strength(s) 9.5MG
Dosage form(s) PATCH
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 30TTSM
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-02
Estimated end date 2024-04-26
Actual end date
Shortage status Actual shortage
Updated date 2024-04-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-04-02 English Compare
v2 2024-04-02 English Compare
v3 2024-04-02 French Compare
v4 2024-04-03 English Compare

Showing 1 to 4 of 4